Initiation of immune checkpoint inhibitor therapy in winter is associated with improved overall survival in patients with advanced non‑small cell lung cancer

Zhangxuan Chen, Jingsi Chen, Yang Yao, Xinjing Li, Ranpu Wu, Bingxue Wang, Jiajie Sun, Hongbing Liu

Open source

DOI
10.3892/ol.2026.15865
Published
2026-09-15
Container
Oncology Letters
Publisher
Spandidos Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ol.2026.15865,
  title = {Initiation of immune checkpoint inhibitor therapy in winter is associated with improved overall survival in patients with advanced non‑small cell lung cancer},
  author = {Zhangxuan Chen and Jingsi Chen and Yang Yao and Xinjing Li and Ranpu Wu and Bingxue Wang and Jiajie Sun and Hongbing Liu},
  year = {2026},
  journal = {Oncology Letters},
  doi = {10.3892/ol.2026.15865},
  url = {https://doi.org/10.3892/ol.2026.15865}
}

RIS

TY  - JOUR
TI  - Initiation of immune checkpoint inhibitor therapy in winter is associated with improved overall survival in patients with advanced non‑small cell lung cancer
AU  - Zhangxuan Chen
AU  - Jingsi Chen
AU  - Yang Yao
AU  - Xinjing Li
AU  - Ranpu Wu
AU  - Bingxue Wang
AU  - Jiajie Sun
AU  - Hongbing Liu
PY  - 2026
JO  - Oncology Letters
DO  - 10.3892/ol.2026.15865
UR  - https://doi.org/10.3892/ol.2026.15865
ER  - 

APA

Chen, Z., Chen, J., Yao, Y., Li, X., Wu, R., Wang, B., Sun, J., & Liu, H. (2026). Initiation of immune checkpoint inhibitor therapy in winter is associated with improved overall survival in patients with advanced non‑small cell lung cancer. Oncology Letters. https://doi.org/10.3892/ol.2026.15865

Source records